Brain-derived neurotrophic factor is related with adverse cardiac remodeling and high NTproBNP

Martin Bahls,Stephanie Könemann,Marcello R. P. Markus,Kristin Wenzel,Nele Friedrich,Matthias Nauck,Henry Völzke,Antje Steveling,Deborah Janowitz,Hans-Jörgen Grabe,Stephan B. Felix,Marcus Dörr
DOI: https://doi.org/10.1038/s41598-019-51776-8
IF: 4.6
2019-10-28
Scientific Reports
Abstract:Abstract The brain-derived neurotrophic factor (BDNF) is a neuronal growth factor essential for normal cardiac contraction and relaxation. Alterations in BDNF signaling are related to the development of cardiovascular disease. Whether BDNF is related to subclinical cardiac remodeling is unclear. We related BDNF with echocardiographic parameters and NTproBNP in a large population-based cohort (n = 2,976, median age 48 years; 45% male). Transthoracic echocardiography was performed on all subjects and BDNF was measured by ELISA. Study participants with severe kidney dysfunction, previous myocardial infarction, and LV ejection fraction <40% were excluded. Linear regression models were adjusted for age, sex, lean mass, fat mass, current smoking, systolic blood pressure and depression. Low BDNF was associated with high NTproBNP. A 10,000 pg/ml lower BDNF was related with a 2.5 g higher (95%-confidence interval [CI]: 0.2 to 4.9; p = 0.036) LV mass, 0.01 cm posterior wall thickness (0.003 to 0.022; p = 0.007) and 0.02 E/A ratio (0.003 to 0.042, p = 0.026). Here we show that low BDNF levels are related with adverse cardiac remodeling and higher levels of NTproBNP. Further research is warranted to assess if BDNF may be used to monitor neuronal-cardiac damage during CVD progression.
multidisciplinary sciences
What problem does this paper attempt to address?